James Vander

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
Phone215-928-3300
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dmitriev PM, Li Y, Vander JF, Wasserman BN. Macular chorioretinal scar a as rare complication of serous retinal detachment in retinopathy of prematurity. BMJ Case Rep. 2024 Nov 14; 17(11). PMID: 39542504.
      Citations:    
    2. Samuelson AG, Patel SN, Kommareddy K, Momenaei B, Yu-Chuan Kang E, Chaudhary V, Hsu J, Dunn JP, Vander JF, Garg SJ. Outcomes of Post-Cataract Surgery Endophthalmitis Managed Without Microbial Cultures. Ophthalmol Retina. 2024 Jul 20. PMID: 39038541.
      Citations:    
    3. Durrani AF, Momenaei B, Wakabayashi T, Vemula S, Pandit SA, Hsu J, Ho AC, Spirn MJ, Klufas MA, Garg SJ, Vander JF, Regillo CD, Chiang A, Kuriyan AE, Yonekawa Y. Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema. Br J Ophthalmol. 2024 Feb 12. PMID: 38346854.
      Citations:    
    4. Momenaei B, Wakabayashi T, Kazan AS, Oh G, Kozarsky S, Vander JF, Gupta OP, Yonekawa Y, Hsu J. Incidence and Outcomes of Recurrent Retinal Detachment After Cataract Surgery in Eyes with Prior Retinal Detachment Repair. Ophthalmol Retina. 2023 Nov 19. PMID: 37989465.
      Citations:    
    5. Park JG, Adrean SD, Begaj T, Capone A, Charles S, Chen SN, Chou HD, Cohen MN, Corona ST, Faia LJ, Garg SJ, Garretson BR, Gregori NZ, Haller JA, Houghton OM, Hsu J, Jo J, Kaiser RS, Lai CC, Mahgoub MM, Mansoor M, Matoba R, Morizane Y, Nehemy MB, Raphaelian PV, Regillo CD, Ruby AJ, Runner MM, Sneed SR, Sohn EH, Spirn MJ, Vander JF, Wakabayashi T, Wolfe JD, Wykoff CC, Yonekawa Y, Yoon YH, Mahmoud TH. Surgical Management of Full Thickness Macular Holes in Macular Telangiectasia Type 2.A Global Multicenter Study. Ophthalmology. 2023 Sep 01. PMID: 37661066.
      Citations:    
    6. Vander JF, Fineman MS, Garg S, Regillo CD. Comment on: Perspective: A caveat about financial incentives for anti-vascular endothelial growth factor therapy for diabetic retinopathy. Am J Ophthalmol. 2023 Mar 03. PMID: 36871889.
      Citations:    
    7. Patel SN, Cai LZ, Mahmoudzadeh R, Salabati M, Magan T, Obeid A, Soares RR, Hinkle JW, Hsu J, Dunn JP, Vander JF, Garg SJ. Endophthalmitis After Intravitreal Anti-Vascular Endothelial Factor Injections: Outcomes of Eyes Managed Without Microbiologic Cultures. Am J Ophthalmol. 2022 03; 235:1-6. PMID: 34461083.
      Citations:    
    8. Salabati M, Mahmoudzadeh R, Wong JC, Patel D, Patel SN, Obeid A, Sivalingam A, Vander JF, Garg SJ, Ho AC, Regillo CD, Hsu J. Outcomes of eyes with retinal vein occlusion that are lost to follow-up after antivascular endothelial growth factor therapy. Br J Ophthalmol. 2022 12; 106(12):1742-1747. PMID: 34183325.
      Citations:    
    9. Vander JF. Long-term Macular Effects of Pentosan Polysulfate Sodium Exposure Uncertain-Let's Not Jump to Conclusions. JAMA Ophthalmol. 2021 03 01; 139(3):364. PMID: 33538763.
      Citations:    
    10. Kuley B, Storey PP, Wibbelsman TD, Pancholy M, Zhang QE, Sharpe J, Bello N, Obeid A, Regillo C, Kaiser RS, Chiang A, Fineman MS, Vander JF, Gupta OP, Spirn MJ, Dunn JP, Mehta S, Park CH, Maguire JI, Garg S. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide. Curr Eye Res. 2021 06; 46(6):824-830. PMID: 33522311.
      Citations:    
    11. Patel SN, Hsu J, Sivalingam MD, Chiang A, Kaiser RS, Mehta S, Park CH, Regillo CD, Sivalingam A, Vander JF, Ho AC, Garg SJ. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2021 02; 222:194-201. PMID: 32888902.
      Citations:    
    12. Patel SN, Storey PP, Levin H, Pancholy M, Obeid A, Wibbelsman TD, Kuley B, Ho AC, Hsu J, Garg SJ, Vander JF, Dunn JP. Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic Cultures. Ophthalmol Retina. 2021 01; 5(1):16-22. PMID: 32599176.
      Citations:    
    13. Hsu J, Patel SN, Wolfe JD, Shah CP, Chen E, Jenkins TL, Wibbelsman TD, Obeid A, Mikhail M, Garg SJ, Ho AC, Chiang A, Spirn MJ, Vander JF. Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial. JAMA Ophthalmol. 2020 05 01; 138(5):560-567. PMID: 32239190.
      Citations:    
    14. Patel SN, Storey PP, Pancholy M, Obeid A, Wibbelsman TD, Levin H, Hsu J, Garg SJ, Dunn JP, Vander JF. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection. Am J Ophthalmol. 2019 11; 207:224-231. PMID: 31201794.
      Citations:    
    15. Gao X, Obeid A, Aderman CM, Ali FS, Vander JF, Hsu J, Ho AC. Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Macular Edema Associated With Central Retinal Vein Occlusion in Patients Age 40 Years or Younger. Ophthalmic Surg Lasers Imaging Retina. 2019 04 01; 50(4):e96-e104. PMID: 30998252.
      Citations:    
    16. London NJS, Kaiser RS, Khan MA, Alshareef RA, Khuthaila M, Shahlaee A, Obeid A, London VA, DeCroos FC, Gupta OP, Hsu J, Vander JF, Spirn MJ, Regillo CD. Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial. Br J Ophthalmol. 2019 09; 103(9):1306-1313. PMID: 30381390.
      Citations:    
    17. Rahimy E, Pitcher JD, Hsu J, Adam MK, Shahlaee A, Samara WA, Vander JF, Kaiser RS, Chiang A, Spirn MJ, Fineman MS. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR). Retina. 2018 May; 38(5):962-969. PMID: 28426624.
      Citations:    
    18. Chiang A, Cohen MN, Houston SK, Juhn A, Ho AC, Regillo CD, Vander JF. Re: Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion. Can J Ophthalmol. 2017 02; 52(1):137-138. PMID: 28237140.
      Citations:    
    19. Garg SJ, Dollin M, Hsu J, Storey P, Vander JF. Effect of a Strict 'No-Talking' Policy During Intravitreal Injection on Post-Injection Endophthalmitis. Ophthalmic Surg Lasers Imaging Retina. 2015 Nov-Dec; 46(10):1028-34. PMID: 26599245.
      Citations:    
    20. Witkin AJ, Rayess N, Garg SJ, Maguire JI, Storey P, Kaiser RS, Hsu J, Vander JF, Ho AC. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment. Semin Ophthalmol. 2017; 32(3):309-315. PMID: 26337539.
      Citations:    
    21. Sridhar J, Shahlaee A, Vander JF. En Face Optical Coherence Tomography of Subfoveal Perfluorocarbon Liquid. Ophthalmology. 2015 Sep; 122(9):1853. PMID: 26299723.
      Citations:    
    22. Rayess N, Rahimy E, Vander JF, Spirn MJ, Chiang A, Garg SJ, Hsu J. Spectral-Domain Optical Coherence Tomography in Acute Posterior Vitreous Detachment. Ophthalmology. 2015 Sep; 122(9):1946-7. PMID: 25935788.
      Citations:    
    23. Salz DA, Pitcher JD, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina. 2015 Apr; 46(4):439-44. PMID: 25970864.
      Citations:    
    24. Rayess N, Rahimy E, Ying GS, Bagheri N, Ho AC, Regillo CD, Vander JF, Hsu J. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol. 2015 Jan; 159(1):85-91.e1-3. PMID: 25261844.
      Citations:    
    25. Hsu J, Gerstenblith AT, Garg SJ, Vander JF. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014 Mar; 157(3):514-8.e1. PMID: 24332373.
      Citations:    
    26. Bansal AS, Hsu J, Garg SJ, Sivalingam A, Vander JF, Moster M, Maguire JI, Regillo CD. Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factors. Ophthalmology. 2012 Nov; 119(11):2364-70. PMID: 22840420.
      Citations:    
    27. Kaiser RS, Gupta OP, Regillo CD, Ho AC, Fineman MS, Vander JF, McNamara JA, Brown GC. Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response. Ophthalmic Surg Lasers Imaging. 2012 Jan-Feb; 43(1):13-9. PMID: 21986085.
      Citations:    
    28. Rezeq SS, Vander JF, Hsu J, Regillo CD, Ho AC, Garg SJ, Spirn MJ. Iatrogrenic retinal breaks. Ophthalmology. 2011 Aug; 118(8):1696, 1696.e1; author reply 1697. PMID: 21813104.
      Citations:    
    29. Baker PS, Spirn MJ, Chiang A, Regillo CD, Ho AC, Vander JF, Kaiser RS. 23-Gauge transconjunctival pars plana vitrectomy for removal of retained lens fragments. Am J Ophthalmol. 2011 Oct; 152(4):624-7. PMID: 21726843.
      Citations:    
    30. Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011 Oct; 118(10):2028-34. PMID: 21705087.
      Citations:    
    31. Baskin DE, Gault JA, Vander JF, Dugan JD. Double fovea artifact. Ophthalmology. 2011 Feb; 118(2):429.e1. PMID: 21292120.
      Citations:    
    32. Shah CP, Ho AC, Regillo CD, Fineman MS, Vander JF, Brown GC. Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment. Retina. 2008 May; 28(5):723-8. PMID: 18463516.
      Citations:    
    33. Hsu J, Kaiser RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, Vander JF, Regillo CD, Ho AC. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina. 2007 Oct; 27(8):1013-9. PMID: 18040237.
      Citations:    
    34. Chen E, Kaiser RS, Vander JF. Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration. Retina. 2007 Apr-May; 27(4):445-50. PMID: 17420696.
      Citations:    
    35. Lin JC, Vander JF, Martin M, Katz LJ. Atypical retinitis pigmentosa masquerading as primary open angle glaucoma. J Glaucoma. 2007 Mar; 16(2):268-70. PMID: 17473745.
      Citations:    
    36. Hsu J, Chen E, Vander JF. Cytomegalovirus retinitis after treatment with intravitreal triamcinolone acetonide in an immunocompetent patient. Retin Cases Brief Rep. 2007; 1(4):208-10. PMID: 25390979.
      Citations:    
    37. Weichel ED, Martidis A, Fineman MS, McNamara JA, Park CH, Vander JF, Ho AC, Brown GC. Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment. Ophthalmology. 2006 Nov; 113(11):2033-40. PMID: 17074564.
      Citations:    
    38. Hurley BR, McNamara JA, Fineman MS, Ho AC, Tasman W, Kaiser RS, Vander JF, Regillo CD, Brown GC. Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years. Retina. 2006 Sep; 26(7 Suppl):S16-7. PMID: 16946671.
      Citations:    
    39. Vander JF, McNamara JA, Tasman W, Brown GC. Revised indications for early treatment of retinopathy of prematurity. Arch Ophthalmol. 2005 Mar; 123(3):406-7; discussion 409-10. PMID: 15767491.
      Citations:    
    40. Shah GK, Vander J. Bilateral presumed endogenous candida endophthalmitis and stage 3 retinopathy of prematurity. Am J Ophthalmol. 2003 May; 135(5):747-8; author reply 748. PMID: 12719106.
      Citations:    
    41. Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology. 2002 May; 109(5):936-41. PMID: 11986101.
      Citations:    
    42. Ng EY, Connolly BP, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology. 2002 May; 109(5):928-34; discussion 935. PMID: 11986099.
      Citations:    
    Vander's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (165)
    Explore
    _
    Co-Authors (26)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _